49
Participants
Start Date
November 16, 2016
Primary Completion Date
December 23, 2016
Study Completion Date
May 31, 2017
Cohort 1: Lubiprostone Capsule, Fasted
Lubiprostone soft gelatin capsule administered under fasted conditions
Cohort 1: Lubiprostone Sprinkle Formulation, Fasted
Lubiprostone sprinkle formulation administered under fasted conditions
Cohort 2: Lubiprostone Sprinkle Formulation, Fed
Lubiprostone sprinkle formulation administered under fed conditions
Cohort 2: Lubiprostone Sprinkle Formulation, Fasted
Lubiprostone sprinkle formulation administered under fasted conditions
ICON, San Antonio
Collaborators (1)
Takeda
INDUSTRY
Sucampo Pharma Americas, LLC
INDUSTRY